Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $75.65 million. The enterprise value is $56.57 million.
| Market Cap | 75.65M |
| Enterprise Value | 56.57M |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.45 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 16.45M |
| Shares Outstanding | 16.45M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 16.60% |
| Owned by Institutions (%) | 25.08% |
| Float | 13.72M |
Valuation Ratios
The trailing PE ratio is 41.69 and the forward PE ratio is 13.40.
| PE Ratio | 41.69 |
| Forward PE | 13.40 |
| PS Ratio | 1.90 |
| Forward PS | 1.52 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | 16.20 |
| P/OCF Ratio | 16.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.12, with an EV/FCF ratio of 12.22.
| EV / Earnings | 31.41 |
| EV / Sales | 1.43 |
| EV / EBITDA | 20.12 |
| EV / EBIT | 22.12 |
| EV / FCF | 12.22 |
Financial Position
The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.06 |
| Quick Ratio | 5.52 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.22 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 3.03%.
| Return on Equity (ROE) | 3.46% |
| Return on Assets (ROA) | 2.72% |
| Return on Invested Capital (ROIC) | 3.03% |
| Return on Capital Employed (ROCE) | 4.78% |
| Revenue Per Employee | $731,259 |
| Profits Per Employee | $33,352 |
| Employee Count | 54 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.02 |
Taxes
In the past 12 months, SRTS has paid $1.66 million in taxes.
| Income Tax | 1.66M |
| Effective Tax Rate | 47.93% |
Stock Price Statistics
The stock price has decreased by -15.13% in the last 52 weeks. The beta is 1.29, so SRTS's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -15.13% |
| 50-Day Moving Average | 4.68 |
| 200-Day Moving Average | 5.91 |
| Relative Strength Index (RSI) | 41.86 |
| Average Volume (20 Days) | 54,200 |
Short Selling Information
The latest short interest is 834,756, so 5.08% of the outstanding shares have been sold short.
| Short Interest | 834,756 |
| Short Previous Month | 898,553 |
| Short % of Shares Out | 5.08% |
| Short % of Float | 6.09% |
| Short Ratio (days to cover) | 9.58 |
Income Statement
In the last 12 months, SRTS had revenue of $39.49 million and earned $1.80 million in profits. Earnings per share was $0.11.
| Revenue | 39.49M |
| Gross Profit | 22.12M |
| Operating Income | 2.56M |
| Pretax Income | 6.45M |
| Net Income | 1.80M |
| EBITDA | 2.81M |
| EBIT | 2.56M |
| Earnings Per Share (EPS) | $0.11 |
Balance Sheet
The company has $19.07 million in cash and $654,000 in debt, giving a net cash position of $18.42 million or $1.12 per share.
| Cash & Cash Equivalents | 19.07M |
| Total Debt | 654,000 |
| Net Cash | 18.42M |
| Net Cash Per Share | $1.12 |
| Equity (Book Value) | 53.03M |
| Book Value Per Share | 3.22 |
| Working Capital | 47.47M |
Cash Flow
In the last 12 months, operating cash flow was $4.68 million and capital expenditures -$50,000, giving a free cash flow of $4.63 million.
| Operating Cash Flow | 4.68M |
| Capital Expenditures | -50,000 |
| Free Cash Flow | 4.63M |
| FCF Per Share | $0.28 |
Margins
Gross margin is 56.02%, with operating and profit margins of 6.48% and 4.56%.
| Gross Margin | 56.02% |
| Operating Margin | 6.48% |
| Pretax Margin | 8.76% |
| Profit Margin | 4.56% |
| EBITDA Margin | 7.12% |
| EBIT Margin | 6.48% |
| FCF Margin | 11.72% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.50% |
| Shareholder Yield | -0.50% |
| Earnings Yield | 2.40% |
| FCF Yield | 6.17% |
Analyst Forecast
The average price target for SRTS is $11.67, which is 153.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.67 |
| Price Target Difference | 153.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 12.66% |
| EPS Growth Forecast (5Y) | -5.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 10.17 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.17 |
| Piotroski F-Score | 5 |